SpaceX shares rise even as company insiders get a chance to sell for the first time
- SpaceX shares rose 6.1% to close at $114.92 despite insiders being freed to sell their shares for the first time.
- More than 900 million shares became newly available for trading with the expiration of lockup provisions.
- The stock had previously experienced a significant drop of nearly 14% a day before this rise.
- Morgan Stanley analysts predict the stock could rise to $300 by mid-next year, nearly triple its current level.
- SpaceX reported a loss of $541 million in the last quarter, but revenue increased by over 90% compared to the previous year.
Stock in Elon Musk’s space company rose Thursday even after many SpaceX insiders were freed up to sell for the first time. Investors in SpaceX have pushed the shares down sharply in recent days in anticipation of insiders possibly selling in the first of several so-called lockup expirations that free them up to trade.
More than 900 million shares became newly available to buy or sell with Thursday’s release, doubling what was available previously. SpaceX shares rose 6.1% to close at $114.92. A day earlier they had one of their biggest routs in SpaceX’s short history as a public company, dropping nearly 14%.
Morgan Stanley analyst Adam Jonas said the expiration of lockup provisions that bar employees and others from selling was an opportunity for others to get into the stock cheaply. He believes the stock could rise to $300 by the middle of next year, nearly triple its current level. Earlier this week, SpaceX reported it had lost $541 million, or 9 cents per share, in the three months through June, less than half what financial analysts had forecast.
SpaceX股价上涨，即便公司内部人士首次获得出售机会
埃隆·马斯克的太空公司SpaceX的股价在周四上涨，尽管许多内部人士首次获得出售股票的机会。近期，投资者因预期内部人士可能会在几次锁定期到期中出售股票而大幅压低股价。
随着周四的解禁，超过9亿股股票首次可供买卖，几乎是之前可交易数量的两倍。SpaceX股价上涨6.1%，收于114.92美元。前一天，股价曾经历了SpaceX作为上市公司以来最大的一次暴跌，跌幅近14%。
摩根士丹利分析师亚当·乔纳斯表示，锁定期条款的到期为其他投资者提供了以较低价格进入股票的机会。他认为，股价到明年中期可能上涨至300美元，几乎是当前水平的三倍。早些时候，SpaceX报告称，在截至6月的三个月中亏损5.41亿美元，或每股9美分，远低于金融分析师的预期。